Glen Eagle Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.56K | Sell |
4
-3
| -43% | -$1.17K | ﹤0.01% | 873 |
|
2025
Q1 | $3.06K | Hold |
7
| – | – | ﹤0.01% | 794 |
|
2024
Q4 | $2.59K | Sell |
7
-4
| -36% | -$1.48K | ﹤0.01% | 840 |
|
2024
Q3 | $5.73K | Hold |
11
| – | – | ﹤0.01% | 741 |
|
2024
Q2 | $5.97K | Buy |
11
+7
| +175% | +$3.8K | ﹤0.01% | 737 |
|
2024
Q1 | $2.07K | Hold |
4
| – | – | ﹤0.01% | 901 |
|
2023
Q4 | $1.89K | Hold |
4
| – | – | ﹤0.01% | 869 |
|
2023
Q3 | $1.74K | Hold |
4
| – | – | ﹤0.01% | 877 |
|
2023
Q2 | $1.78K | Hold |
4
| – | – | ﹤0.01% | 886 |
|
2023
Q1 | $1.84K | Buy |
4
+2
| +100% | +$920 | ﹤0.01% | 865 |
|
2022
Q4 | $1.03K | Buy |
+2
| New | +$1.03K | ﹤0.01% | 1014 |
|
2021
Q3 | – | Sell |
-27
| Closed | -$10.3K | – | 1068 |
|
2021
Q2 | $10.3K | Hold |
27
| – | – | ﹤0.01% | 687 |
|
2021
Q1 | $9.69K | Hold |
27
| – | – | ﹤0.01% | 674 |
|
2020
Q4 | $8.67K | Hold |
27
| – | – | ﹤0.01% | 658 |
|
2020
Q3 | $7.25K | Hold |
27
| – | – | ﹤0.01% | 647 |
|
2020
Q2 | $7.1K | Hold |
27
| – | – | ﹤0.01% | 614 |
|
2020
Q1 | $6.13K | Hold |
27
| – | – | ﹤0.01% | 591 |
|
2019
Q4 | $8.16K | Hold |
27
| – | – | ﹤0.01% | 630 |
|
2019
Q3 | $6.48K | Hold |
27
| – | – | ﹤0.01% | 589 |
|
2019
Q2 | $7.62K | Buy |
27
+17
| +170% | +$4.8K | 0.01% | 545 |
|
2019
Q1 | $2.87K | Buy |
+10
| New | +$2.87K | ﹤0.01% | 628 |
|
2018
Q4 | – | Sell |
-26
| Closed | -$7.13K | – | 728 |
|
2018
Q3 | $7.13K | Buy |
26
+9
| +53% | +$2.47K | 0.01% | 512 |
|
2018
Q2 | $4.05K | Buy |
+17
| New | +$4.05K | ﹤0.01% | 567 |
|